THOMAS W BURKE to Humans
This is a "connection" page, showing publications THOMAS W BURKE has written about Humans.
Connection Strength
0.285
-
Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30.
Score: 0.009
-
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9.
Score: 0.009
-
The implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on cancer care delivery. Cancer. 2011 Apr 15; 117(8):1564-74.
Score: 0.008
-
A method for defining value in healthcare using cancer care as a model. J Healthc Manag. 2010 Nov-Dec; 55(6):399-411; discussion 411-2.
Score: 0.008
-
Meeting local needs while developing public health practice skills: a model community-academic partnership. J Public Health Manag Pract. 2009 Sep-Oct; 15(5):425-31.
Score: 0.007
-
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
Score: 0.007
-
New membership model. Gynecol Oncol. 2009 Jan; 112(1):4-5.
Score: 0.007
-
The origins of multidisciplinary cancer care. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S2-3.
Score: 0.006
-
Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol. 2006 Oct; 103(1):155-9.
Score: 0.005
-
Arzoxifene as therapy for endometrial cancer. Gynecol Oncol. 2003 Aug; 90(2 Pt 2):S40-6.
Score: 0.005
-
Uncovering the historic environmental hazards of urban brownfields. J Urban Health. 2002 Dec; 79(4):464-81.
Score: 0.004
-
Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9.
Score: 0.004
-
Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6.
Score: 0.004
-
Examining urban brownfields through the public health "macroscope". Environ Health Perspect. 2002 Apr; 110 Suppl 2:183-93.
Score: 0.004
-
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol. 2002 Jan; 97(1):32-9.
Score: 0.004
-
A comparison of host response strategies to distinguish bacterial and viral infection. PLoS One. 2021; 16(12):e0261385.
Score: 0.004
-
Early cervical cancer. Curr Treat Options Oncol. 2000 Jun; 1(2):147-55.
Score: 0.004
-
Adjuvant chemotherapy for high-risk endometrial cancer. Semin Radiat Oncol. 2000 Jan; 10(1):23-8.
Score: 0.004
-
Opportunities and Challenges for Dietary Arsenic Intervention. Environ Health Perspect. 2018 08; 126(8):84503.
Score: 0.003
-
How should we monitor women treated for endometrial carcinoma? Gynecol Oncol. 1997 Jun; 65(3):377-8.
Score: 0.003
-
Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70.
Score: 0.003
-
Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma. Clin Obstet Gynecol. 1996 Sep; 39(3):716-27.
Score: 0.003
-
Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996 Aug; 62(2):169-73.
Score: 0.003
-
Endometrial hyperplasia and endometrial cancer. Obstet Gynecol Clin North Am. 1996 Jun; 23(2):411-56.
Score: 0.003
-
Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Apr; 61(1):27-30.
Score: 0.003
-
Informing 21st-Century Risk Assessments with 21st-Century Science. Environ Health Perspect. 2016 Apr; 124(4):A60-3.
Score: 0.003
-
A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol. 1996 Jan; 60(1):49-53.
Score: 0.003
-
Modified instruments for mobilization of the ureters and parametrial transsection during radical hysterectomy. Ann Surg Oncol. 1995 Sep; 2(5):435-9.
Score: 0.003
-
Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20.
Score: 0.003
-
Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5.
Score: 0.003
-
Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol. 1995 May; 57(2):266-9.
Score: 0.003
-
Histologic characterization of uterine papillary serous adenocarcinoma. Gynecol Oncol. 1995 Mar; 56(3):425-9.
Score: 0.003
-
Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb; 56(2):207-10.
Score: 0.003
-
Clinical aspects of risk in women with endometrial carcinoma. J Cell Biochem Suppl. 1995; 23:131-6.
Score: 0.003
-
Closure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7.
Score: 0.003
-
Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23.
Score: 0.002
-
Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50.
Score: 0.002
-
Metastatic cervical cancer presenting as cholecystitis. Gynecol Oncol. 1994 Aug; 54(2):250-3.
Score: 0.002
-
High-stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types. Am J Surg Pathol. 1994 Jul; 18(7):687-93.
Score: 0.002
-
The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 2014; 9(4):e94167.
Score: 0.002
-
Secondary cytoreductive surgery for ovarian cancer. Obstet Gynecol Clin North Am. 1994 Mar; 21(1):167-78.
Score: 0.002
-
Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300.
Score: 0.002
-
Limited endometrial carcinoma: adjuvant therapy. Semin Oncol. 1994 Feb; 21(1):84-90.
Score: 0.002
-
Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400.
Score: 0.002
-
Quality assessment across a national cancer network. J Oncol Pract. 2013 May; 9(3):165-8.
Score: 0.002
-
Aggressive stage I grade 1 endometrial carcinoma. Cancer. 1992 Aug 15; 70(4):790-8.
Score: 0.002
-
Factors affecting recurrence and survival in stage I carcinoma of the uterine cervix. Oncology (Williston Park). 1992 Feb; 6(2):111-6; discussion 118-9; 122.
Score: 0.002
-
Changing surgical approaches to vulvar cancer. Curr Opin Obstet Gynecol. 1992 Feb; 4(1):86-90.
Score: 0.002
-
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012 May 15; 118(10):2571-82.
Score: 0.002
-
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22.
Score: 0.002
-
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol. 1991 Mar; 40(3):264-7.
Score: 0.002
-
Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol. 1990 Sep; 38(3):328-32.
Score: 0.002
-
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
Score: 0.002
-
Treatment failure in endometrial carcinoma. Obstet Gynecol. 1990 Jan; 75(1):96-101.
Score: 0.002
-
Continuous thoracic epidural analgesia for the control of pain associated with pleural sclerosis. Gynecol Oncol. 1989 Jan; 32(1):76-8.
Score: 0.002
-
Vulvar dermatofibrosarcoma protuberans. Gynecol Oncol. 1988 May; 30(1):149-52.
Score: 0.002
-
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2543-50.
Score: 0.002
-
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008 Aug; 62(3):483-9.
Score: 0.002
-
Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol. 1987 Nov; 28(3):312-7.
Score: 0.002
-
Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):382-5.
Score: 0.001
-
Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987 Feb; 26(2):153-9.
Score: 0.001
-
End colostomy using the end-to-end anastomosis instrument. Obstet Gynecol. 1987 Feb; 69(2):156-9.
Score: 0.001
-
Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.
Score: 0.001
-
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol. 2006 Apr; 101(1):126-31.
Score: 0.001
-
The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005 Dec; 99(3):530-5.
Score: 0.001
-
Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecol Oncol. 2005 Nov; 99(2):472-6.
Score: 0.001
-
Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83.
Score: 0.001
-
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May; 97(2):489-96.
Score: 0.001
-
Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005 May-Jun; 15(3):510-6.
Score: 0.001
-
The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Rev Invest Clin. 2005 May-Jun; 57(3):399-405.
Score: 0.001
-
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005 Mar; 105(3):569-74.
Score: 0.001
-
Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005 Mar; 105(3):575-80.
Score: 0.001
-
Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance. Int J Gynecol Cancer. 2005 Mar-Apr; 15(2):209-16.
Score: 0.001
-
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecol Oncol. 2004 Oct; 95(1):32-6.
Score: 0.001
-
The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol. 2004 Sep 01; 22(17):3517-23.
Score: 0.001
-
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. J Clin Oncol. 2004 Aug 01; 22(15):3126-32.
Score: 0.001
-
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24.
Score: 0.001
-
Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):168-73.
Score: 0.001
-
Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):748-52.
Score: 0.001
-
Malignant mixed M?llerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):786-96.
Score: 0.001
-
Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
Score: 0.001
-
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003 Dec; 91(3):463-9.
Score: 0.001
-
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
Score: 0.001
-
Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
Score: 0.001
-
Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1366-72.
Score: 0.001
-
Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul; 22(3):297-302.
Score: 0.001
-
Sarcomatoid carcinoma of the cervix. Gynecol Oncol. 2003 Jul; 90(1):23-8.
Score: 0.001
-
A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer. Gynecol Oncol. 2003 Jul; 90(1):64-9.
Score: 0.001
-
PTEN expression in tamoxifen-associated endometrial cancers. Anticancer Res. 2002 Sep-Oct; 22(5):2945-8.
Score: 0.001
-
Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81.
Score: 0.001
-
Metastatic uterine papillary serous carcinoma to the pericardium. Gynecol Oncol. 2001 Oct; 83(1):135-7.
Score: 0.001
-
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol. 2001 Sep; 82(3):420-6.
Score: 0.001
-
Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.
Score: 0.001
-
Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61.
Score: 0.001
-
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.
Score: 0.001
-
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res. 2000 Jan; 6(1):278-84.
Score: 0.001
-
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300.
Score: 0.001
-
Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41.
Score: 0.001
-
The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999 Feb 15; 85(4):905-11.
Score: 0.001
-
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gynecol Oncol. 1998 Sep; 70(3):404-9.
Score: 0.001
-
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8.
Score: 0.001
-
Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1998 Aug; 70(2):241-6.
Score: 0.001
-
Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998 Mar 15; 82(6):1096-103.
Score: 0.001
-
Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8.
Score: 0.001
-
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997 Aug 15; 127(4):267-74.
Score: 0.001
-
An outcomes management program in gynecologic oncology. Obstet Gynecol. 1997 Apr; 89(4):485-92.
Score: 0.001
-
Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7.
Score: 0.001
-
Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35.
Score: 0.001
-
A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol. 1996 Oct; 63(1):25-7.
Score: 0.001
-
Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6.
Score: 0.001
-
Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother. 1996 Sep; 40(9):1995-7.
Score: 0.001
-
Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.
Score: 0.001
-
Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996 Jul; 62(1):73-7.
Score: 0.001
-
Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31.
Score: 0.001
-
Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5.
Score: 0.001
-
Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.
Score: 0.001
-
Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995 Nov; 59(2):221-5.
Score: 0.001
-
Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44.
Score: 0.001
-
Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6.
Score: 0.001
-
Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55.
Score: 0.001
-
Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93.
Score: 0.001
-
Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5.
Score: 0.001
-
Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995 Jul; 19(7):769-74.
Score: 0.001
-
Infusion site soft-tissue injury after paclitaxel administration. Cancer. 1995 Jul 01; 76(1):116-20.
Score: 0.001
-
Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9.
Score: 0.001
-
Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.
Score: 0.001
-
Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. Gynecol Oncol. 1995 Jan; 56(1):34-8.
Score: 0.001
-
Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42.
Score: 0.001
-
Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10.
Score: 0.001
-
Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994 Oct; 55(1):29-35.
Score: 0.001
-
Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug; 84(2):163-7.
Score: 0.001
-
A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8.
Score: 0.001
-
Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol. 1994 Apr; 13(2):127-30.
Score: 0.001
-
Intraoperative radiographs to confirm the adequacy of lymph node resection in patients with suspicious lymphangiograms. Gynecol Oncol. 1993 Dec; 51(3):362-7.
Score: 0.001
-
Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1993 Nov 15; 27(4):817-24.
Score: 0.001
-
Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84.
Score: 0.001
-
Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol. 1993 Jul; 50(1):94-9.
Score: 0.001
-
Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23.
Score: 0.001
-
Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience. Cancer. 1993 Jan 15; 71(2 Suppl):638-43.
Score: 0.001
-
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992 Oct; 47(1):62-5.
Score: 0.001
-
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered. Gynecol Oncol. 1992 Oct; 47(1):7-13.
Score: 0.001
-
Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21.
Score: 0.001
-
Pelvic exenteration in the elderly patient. Obstet Gynecol. 1992 May; 79(5 ( Pt 1)):773-7.
Score: 0.001
-
Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9.
Score: 0.001
-
Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol. 1992 Mar; 44(3):240-4.
Score: 0.001
-
Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administration. J Natl Cancer Inst. 1991 Nov 20; 83(22):1629-36.
Score: 0.001
-
Splenectomy in gynecologic oncology: indications, complications, and technique. Gynecol Oncol. 1991 Nov; 43(2):118-22.
Score: 0.001
-
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 1991 Aug; 42(2):146-50.
Score: 0.000
-
Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205.
Score: 0.000
-
Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5.
Score: 0.000
-
Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 1991 Feb; 77(2):271-5.
Score: 0.000
-
Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec; 76(6):1020-4.
Score: 0.000
-
Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990 Dec; 39(3):337-46.
Score: 0.000
-
Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis. Gynecol Oncol. 1990 Sep; 38(3):305-8.
Score: 0.000
-
Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol. 1990 Mar; 36(3):435-8.
Score: 0.000
-
Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990 Feb; 36(2):189-91.
Score: 0.000
-
Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol. 1989 Dec; 74(6):930-3.
Score: 0.000
-
Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol. 1989 Nov; 35(2):275-8.
Score: 0.000
-
Widespread lymph node metastases in a patient with microinvasive cervical carcinoma. Gynecol Oncol. 1989 Aug; 34(2):219-21.
Score: 0.000
-
Methotrexate-induced erythema multiforme. Gynecol Oncol. 1989 Jun; 33(3):376-8.
Score: 0.000
-
Endodermal sinus tumor of the infant vagina treated exclusively by chemotherapy. Obstet Gynecol. 1989 Mar; 73(3 Pt 2):507-9.
Score: 0.000
-
Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol. 1988 Jun; 30(2):201-8.
Score: 0.000
-
Retroperitoneal nerve sheath tumors: an unusual cause of pelvic mass. Obstet Gynecol. 1988 Jun; 71(6 Pt 2):1050-2.
Score: 0.000
-
Diagnosis of recurrent gynecologic malignancy with fine-needle aspiration cytology. Obstet Gynecol. 1988 Mar; 71(3 Pt 1):333-7.
Score: 0.000
-
The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):502-4.
Score: 0.000
-
Retroperitoneal teratoma presenting as an abdominal-pelvic mass. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):500-2.
Score: 0.000
-
Calyceal rupture with perirenal urinoma in a patient with cervical carcinoma. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):511-3.
Score: 0.000
-
Biologic course of cervical human papillomavirus infection. Obstet Gynecol. 1987 Feb; 69(2):160-2.
Score: 0.000
-
Right hemicolectomy and ileal resection with primary reanastomosis for irradiation injury of the terminal ileum. Gynecol Oncol. 1987 Feb; 26(2):215-24.
Score: 0.000